The latter may be achieved through the transfer of antigen specific CD4+ T cells in tandem with CD8+ T cell clones to enhance the effector function/proliferative ability of CD8+ cell, and independently provide anti-tumor activity. The gene discussed is CD8A; the disease is neoplasm.